FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2765486507> ?p ?o ?g. }

• W2765486507 endingPage "102096" @default.
• W2765486507 startingPage "102088" @default.
• W2765486507 abstract "// Liangjing Xu 1, 2, 3, 4, * , Jinge Xu 1, 2, 3, 4, 5, * , Shoubao Ma 2, 3, 4, * , Xiaoli Li 1, 2, 3, 4 , Mingqing Zhu 1, 2, 3, 4 , Suning Chen 1, 2, 3, 4 , Yue Han 1, 2, 3, 4 , Xiaowen Tang 1, 2, 3, 4 , Zhengzheng Fu 1, 2, 3, 4 , Huiying Qiu 1, 2, 3, 4 , Jianhua Yu 6 , Depei Wu 1, 2, 3, 4 and Xiaojin Wu 1, 2, 3, 4 1 Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China 2 Institute of Blood and Marrow Transplantation, Suzhou, China 3 Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China 4 Key Laboratory of Thrombosis and Hemostasis of Ministry of Health, Suzhou, China 5 The Second Affiliated Hospital of Xuzhou Medical University, Xuzhou, China 6 The Ohio State University, Comprehensive Cancer Center, Columbus, OH, USA * These authors contributed equally to this work Correspondence to: Depei Wu, email: wudepei@medmail.com.cn Jianhua Yu, email: Jianhua.yu@osumc.edu Xiaojin Wu, email: wuxiaojin@suda.edu.cn Keywords: Tim-3; acute leukemia; expression; chemotherapy Received: June 14, 2017      Accepted: August 17, 2017      Published: October 27, 2017 ABSTRACT T-cell immunoglobulin and mucin domain-containing molecule3 (Tim-3) represents a novel mechanism of T-cell dysfunction and exhaustion. Tim-3 has also been identified in various solid tumors. However, the role of Tim-3 expression on blast cells in acute myeloid leukemia (AML) is not well understood. In this study, we aimed to explore the role of Tim-3 in patients with de novo AML, and the correlation between Tim-3 and clinicopathological prognosis. The study cohort consisted of 76 patients with de novo non-M3 AML. These patients’ bone marrow samples were collected and then bone marrow mononuclear cells (BMCs) were isolated for flow cytometry to detect Tim-3 expression on blasts. According to FAB type, 76 diagnosed AML patients included in this study were: M0 (n=2), M1 (n=16), M2 (n=20), M4 (n=20), M5 (n=16), and M6 (n=2). A positive expression (>20%) of Tim-3 was found in 87% (66/76) of patients with AML. The average percentage of Tim-3(+) blasts in these AML patients was 58.26 ± 29.23%. Moreover, the frequency of Tim-3 high expression was higher in M4 patients than that in other AML patients according to FAB type (P=0.004). Tim-3 high expression was also closely associated with inv(16) (P=0.01) and C/EBPA mutation (P=0.03). The mutations of the following six genes, i.e., FLT3-ITD, NPM1, C-KIT, IDH1/IDH2, DNMT3A, were independent of the Tim-3 expression. Additionally, it is more likely to find higher levels of Tim-3 in the low-risk group than in the intermediate- and high-risk groups (P=0.02). The expression of Tim-3 was positively correlated with CD13 (r=0.36, P=0.001), CD34 (r=0.41, P=0.000), and CD7 (r=0.27, P=0.02) in AML patients. AML patients with high Tim-3 expression achieved significantly high complete remission (CR) rate (P=0.01), while their Tim-3 expression significantly decreased after CR (P=0.01). Blockade of Tim-3 expression on AML blasts significantly reduced the Idarubicin (IDA)-mediated suppression of cell growth and reduction of cell apoptosis in vitro . Collectively, our study suggests that high Tim-3 expression on AML blasts could enhances chemotherapy sensitivity." @default.
• W2765486507 created "2017-11-10" @default.
• W2765486507 creator A5004290396 @default.
• W2765486507 creator A5006739024 @default.
• W2765486507 creator A5022501218 @default.
• W2765486507 creator A5025388436 @default.
• W2765486507 creator A5026007102 @default.
• W2765486507 creator A5030108757 @default.
• W2765486507 creator A5032463961 @default.
• W2765486507 creator A5032622609 @default.
• W2765486507 creator A5042921774 @default.
• W2765486507 creator A5063447635 @default.
• W2765486507 creator A5064955096 @default.
• W2765486507 creator A5065640806 @default.
• W2765486507 creator A5076246718 @default.
• W2765486507 date "2017-10-27" @default.
• W2765486507 modified "2023-09-30" @default.
• W2765486507 title "High Tim-3 expression on AML blasts could enhance chemotherapy sensitivity" @default.
• W2765486507 cites W118599346 @default.
• W2765486507 cites W1872256430 @default.
• W2765486507 cites W1980860344 @default.
• W2765486507 cites W1991807494 @default.
• W2765486507 cites W1997731331 @default.
• W2765486507 cites W1999700641 @default.
• W2765486507 cites W2006445674 @default.
• W2765486507 cites W2013177587 @default.
• W2765486507 cites W2014666027 @default.
• W2765486507 cites W2028824678 @default.
• W2765486507 cites W2057658429 @default.
• W2765486507 cites W2059440242 @default.
• W2765486507 cites W2070631889 @default.
• W2765486507 cites W2102413552 @default.
• W2765486507 cites W2107598346 @default.
• W2765486507 cites W2150113701 @default.
• W2765486507 cites W2158240777 @default.
• W2765486507 cites W2167717479 @default.
• W2765486507 cites W2222912217 @default.
• W2765486507 cites W2337195173 @default.
• W2765486507 cites W2395145382 @default.
• W2765486507 cites W2476010535 @default.
• W2765486507 cites W2559537906 @default.
• W2765486507 cites W75864458 @default.
• W2765486507 doi "https://doi.org/10.18632/oncotarget.22141" @default.
• W2765486507 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5731937" @default.
• W2765486507 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29254227" @default.
• W2765486507 hasPublicationYear "2017" @default.
• W2765486507 type Work @default.
• W2765486507 sameAs 2765486507 @default.
• W2765486507 citedByCount "14" @default.
• W2765486507 countsByYear W27654865072019 @default.
• W2765486507 countsByYear W27654865072020 @default.
• W2765486507 countsByYear W27654865072021 @default.
• W2765486507 countsByYear W27654865072022 @default.
• W2765486507 countsByYear W27654865072023 @default.
• W2765486507 crossrefType "journal-article" @default.
• W2765486507 hasAuthorship W2765486507A5004290396 @default.
• W2765486507 hasAuthorship W2765486507A5006739024 @default.
• W2765486507 hasAuthorship W2765486507A5022501218 @default.
• W2765486507 hasAuthorship W2765486507A5025388436 @default.
• W2765486507 hasAuthorship W2765486507A5026007102 @default.
• W2765486507 hasAuthorship W2765486507A5030108757 @default.
• W2765486507 hasAuthorship W2765486507A5032463961 @default.
• W2765486507 hasAuthorship W2765486507A5032622609 @default.
• W2765486507 hasAuthorship W2765486507A5042921774 @default.
• W2765486507 hasAuthorship W2765486507A5063447635 @default.
• W2765486507 hasAuthorship W2765486507A5064955096 @default.
• W2765486507 hasAuthorship W2765486507A5065640806 @default.
• W2765486507 hasAuthorship W2765486507A5076246718 @default.
• W2765486507 hasBestOaLocation W27654865071 @default.
• W2765486507 hasConcept C126322002 @default.
• W2765486507 hasConcept C143998085 @default.
• W2765486507 hasConcept C194409129 @default.
• W2765486507 hasConcept C502942594 @default.
• W2765486507 hasConcept C71924100 @default.
• W2765486507 hasConceptScore W2765486507C126322002 @default.
• W2765486507 hasConceptScore W2765486507C143998085 @default.
• W2765486507 hasConceptScore W2765486507C194409129 @default.
• W2765486507 hasConceptScore W2765486507C502942594 @default.
• W2765486507 hasConceptScore W2765486507C71924100 @default.
• W2765486507 hasIssue "60" @default.
• W2765486507 hasLocation W27654865071 @default.
• W2765486507 hasLocation W27654865072 @default.
• W2765486507 hasLocation W27654865073 @default.
• W2765486507 hasLocation W27654865074 @default.
• W2765486507 hasOpenAccess W2765486507 @default.
• W2765486507 hasPrimaryLocation W27654865071 @default.
• W2765486507 hasRelatedWork W1966560434 @default.
• W2765486507 hasRelatedWork W1985281976 @default.
• W2765486507 hasRelatedWork W1992737179 @default.
• W2765486507 hasRelatedWork W2034483267 @default.
• W2765486507 hasRelatedWork W2748952813 @default.
• W2765486507 hasRelatedWork W2899084033 @default.
• W2765486507 hasRelatedWork W2913940757 @default.
• W2765486507 hasRelatedWork W3031052312 @default.
• W2765486507 hasRelatedWork W4234996855 @default.
• W2765486507 hasRelatedWork W4236018923 @default.
• W2765486507 hasVolume "8" @default.
• W2765486507 isParatext "false" @default.

• next